Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a backend/platform update. This change does not alter the study content, eligibility criteria, or results.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPage revision tag updated from v3.6.2 to v3.6.3. This represents a small update to the page metadata and does not alter displayed study details.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend update to the page. This does not alter study details or visible content.SummaryDifference0.1%

- Check44 days agoChange DetectedNew study-record navigation items have been added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading has been standardized. A banner now shows No longer looking for participants, and the revision/version is updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check51 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer release that likely includes small fixes or enhancements rather than substantive changes to study information.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, reflecting a new page version in the site's revision history. The core study details and content remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.